Diagnostic test for ovarian cancer

Thursday, 01 January, 2009 | Supplied by: Manalto Inc

The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.

The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.

Results are available within a fortnight.

Online: www.healthlinx.com.au
Phone: 03 9208 4200

Proteomics International PromarkerD LDT immunoassay (ELISA)

PromarkerD is a blood test designed to assess an individual's risk of developing chronic...

Cytek cFluor Human B Cell Monitoring Kit

The Cytek cFluor Human B Cell Monitoring Kit identifies B cell subsets in human peripheral blood...

Primerdesign exsig Mag RapidBead Pro Extraction Kit

Primerdesign's exsig Mag RapidBead Pro Extraction Kit is a next-generation, magnetic...

Content from other channels on our network

Online course helps hospitality sector reduce food waste

How this Sydney CBD tower achieved a 6-star NABERS waste rating

From Intent to Impact: Why Execution Defines the Next Phase of Industrial Energy Efficiency

Refrigerant recovery: the overlooked lever in Australia's net-zero transition

Battery fires increase, prompting national battery stewardship

Post-harvest system to improve safety and extend shelf life

Auckland to host IDF World Dairy Summit 2026, registrations now open

Cobram Estate Olives buys California Olive Ranch

Enhancing Food Quality and Safety with METTLER TOLEDO

Fibre-based solution for caps in development

"Targeted supports" launched for former patients of Simon Gordon

Purpose-built acute distress unit within Westmead ED announced

EMR solutions must support evolution and change

An era for AI agents: why healthcare leaders can't afford to manage governance on spreadsheets

Works completed on two new Victorian aged care facilities